Diethylstilbestrol, a Novel ANO1 Inhibitor, Exerts an Anticancer Effect on Non-Small Cell Lung Cancer via Inhibition of ANO1
Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer-related mortality; thus, therapeutic targets continue to be developed. Anoctamin1 (ANO1), a novel drug target considered for the treatment of NSCLC, is a Ca<sup>2+</sup>-activated chloride channel (CaCC) overexpres...
Main Authors: | Yohan Seo, Sung Baek Jeong, Joo Han Woo, Oh-Bin Kwon, Sion Lee, Hye In Oh, Sungwoo Jo, Seon Ju Park, Wan Namkung, Uk Yeol Moon, Sungwoo Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/13/7100 |
Similar Items
-
Novel ANO1 Inhibitor from <i>Mallotus apelta</i> Extract Exerts Anticancer Activity through Downregulation of ANO1
by: Yohan Seo, et al.
Published: (2020-09-01) -
Tissue lipid variations under long term diethylstilbestrol administration
by: Ke, Tai-Lee
Published: (2011) -
Immunomodulatory Effects of Diethylstilbestrol During Prenatal and Adult Life
by: Fenaux, Jillian Beth
Published: (2014) -
Diethylstilbestrol implantation of male swine : effect during extended growth on carcass composition, muscle quality, and palatability /
by: Plimpton, Rodney Fay
Published: (1965) -
Design of Anticancer 2,4-Diaminopyrimidines as Novel Anoctamin 1 (ANO1) Ion Channel Blockers
by: Taewoo Kim, et al.
Published: (2020-11-01)